Galapagos NV Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 11 of 11 Posts
Gilead, Galapagos Slide After FDA Rejects Filgotinib Over Toxicity Concerns
Article By: The Fly Wednesday, August 19, 2020 11:28 AM EST
Mizuho sees the news as a "clear positive" for both AbbVie and Pfizer.
In this article: GILD, GLPG Also: PFE
Read
Galapagos Sinks After FDA Issues Complete Response Letter To Partner Gilead
Article By: The Fly Wednesday, August 19, 2020 7:40 AM EST
Galapagos last night announced that Gilead Sciences received a Complete Response Letter from the FDA for the New Drug Application for filgotinib, an investigational treatment for moderately to severely active rheumatoid arthritis.
In this article: GILD, GLPG
Read
IBI Market Insight: To Profit From Value Disconnect
Article By: Dr. Hung Tran Wednesday, October 30, 2019 2:11 PM EST
Precision medicine therapeutics and companion diagnostics are powering the next wave of innovation.
In this article: RGNX, CYRX, GLPG
Read
Week In Review: Taimei Raises $212 Million For AI Life Science Support Software
Article By: ChinaBio® Today Sunday, October 20, 2019 4:00 AM EST
Deals, financings, trials and approvals in the China bio markets over the past week.
In this article: MPSYF, GLPG
Read
My Favorite Strategies And Stocks For The Long Run In Belgium
Video By: Option Generator Saturday, March 16, 2019 9:30 PM EST
In this video, I zero in on my favorite strategies and what Belgian stocks you should own for the long run.
In this video: GLPG Also: SPY, QQQ, DIA
Watch
ADRs Best & Worst Report - July 11, 2016
Article By: E.B. Capital Markets Monday, July 11, 2016 9:00 AM EST
The average ADR is trading -23.76% below its 52 week high, 2.83% above its 200 dma, has 3.72 days to cover held short, and is expected to grow its EPS by 17.58% next year.
In this article: AXS, AZN, BCE, BMO, CEO, CNQ, ECA, GSK, HMY, KEP, KT, NVO, RDY, RY, SHI, SID, SNP, TU, YZC, SUBCY, GOLD, GSOL, AMRN, DRD, GLPG
Read
Global Market News This Week
Article By: Vivian Lewis Saturday, June 11, 2016 5:04 PM EST
News of global stocks, a big Danish IPO and the latest from international pharma, telco, materials and energy dominated the global investing headlines this week.
In this article: SLB, SQM, VOD, UEC, MXCHY, TCEHY, EWZ, CZZ, ORA, TEVA, GLPG, FBASF, VALE, EC
Read
Best & Worst ADRs To Buy (With Q2 Seasonality Too)
Article By: E.B. Capital Markets Monday, April 4, 2016 1:14 PM EST
After rolling scores to reflect the shift to second quarter seasonality (10 year historical), the average ADR score is 47.79, which is below the four week score of 49.33 and above the eight week average score of 46.85.
In this article: BAP, BBVA, BCE, BCS, CHU, FBR, KOF, ICLR, PRAN, VLRS, GLPG
Read
Unappetizing Headline
Article By: Vivian Lewis Friday, March 4, 2016 6:10 PM EST
China has to cut its exchange rate to preserve its export markets and discourage imports. But if it moves too publicly it will trigger renewed outflows, most in violation of exchange controls.
In this article: OROCF, TTM, VALE, BNS, TEVA, NVO, GSK, RBGLY, INVVY, BNTC, GLPG, INFY, ITYBY, PDYPF, CRH, AZSEY, GLD, CGRIF
Read
Premarket Biotech Digest | Sector News Brief
Article By: KKD Healthcare Analytics Thursday, January 21, 2016 3:12 AM EST
The sector news section of our extended daily premarket digest publication.
In this article: JNJ, TBIO, CASI, AKRX, OSIR, XON, MBVX, GLPG, SMMT
Read
4 Undervalued Bargains To Buy In Biotech
Article By: Bret Jensen Tuesday, January 19, 2016 11:47 PM EST
Sporting their cheapest valuations since 2011 and superior long-term values over the rest of the market, now is the time to shop the bargain bin in biotech. See Bret Jensen’s top four picks to start accumulating today.
In this article: CELG, GILD, MYL, TEVA, ABBV, GLPG
Read
1 to 11 of 11 Posts